Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Accenture plcACN · Entity 2893 | Grp Chief Exec-Com, Med & Tech | July 05, 2018 | July 09, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Accenture plc
Report date July 05, 2018 · Filed July 09, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A ordinary sharesSEC Table I · non-derivative | Direct | 38,088 |
Reported balance
After 2018-07-05 transaction · row 1
1 source rowRow 1 · 2018-07-05 · Grant · Acquired 55 · Balance 38,088 F1: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. |
Filing footnotes · ownership attribution and instrument terms
F1: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 05, 2018 Filed Jul 9, 2018 12:44 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 55 | $164.01 | $9,020.28 |
DisclosureSEC source: 0001467373-18-000242 · wf-form4_153114022508935.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,088 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 20:22 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,550 | $162.79 | $252,331.94 |
DisclosureSEC source: 0001467373-18-000236 · wf-form4_153064932917389.xml · nonDerivative · entry 2 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,033 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $162.58 to $163.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 20:22 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 2,200 | $162.02 | $356,444.00 |
DisclosureSEC source: 0001467373-18-000236 · wf-form4_153064932917389.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,583 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $161.57 to $162.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 05, 2018 Filed Jun 6, 2018 20:43 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 56 | $159.71 | $8,943.48 |
DisclosureSEC source: 0001467373-18-000218 · wf-form4_152831777101352.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,783 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| May 15, 2018 Filed May 17, 2018 22:00 UTC | Accenture plc ACN · Entity 2893 | GrantAccenture plc Class A ordinary shares | 22 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-18-000208 · wf-form4_152659437056204.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,727 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| May 05, 2018 Filed May 8, 2018 12:35 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 60 | $152.15 | $9,129.15 |
DisclosureSEC source: 0001467373-18-000189 · wf-form4_152578290162001.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,705 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 20:41 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 400 | $154.23 | $61,690.52 |
DisclosureSEC source: 0001467373-18-000178 · wf-form4_152451606561270.xml · nonDerivative · entry 3 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,645 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F4 · price: The transaction was executed in multiple trades at prices ranging from $154.02 to $154.525. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 20:41 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,000 | $153.45 | $153,449.00 |
DisclosureSEC source: 0001467373-18-000178 · wf-form4_152451606561270.xml · nonDerivative · entry 2 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,045 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $153.02 to $153.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 20:41 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 2,350 | $152.53 | $358,443.86 |
DisclosureSEC source: 0001467373-18-000178 · wf-form4_152451606561270.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,045 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $152.05 to $152.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 05, 2018 Filed Apr 6, 2018 20:37 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 59 | $151.04 | $8,911.36 |
DisclosureSEC source: 0001467373-18-000159 · wf-form4_152304704209763.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,395 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 21:35 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 57 | $158.33 | $9,024.53 |
DisclosureSEC source: 0001467373-18-000127 · wf-form4_152037211840646.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,336 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 14:10 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 58 | $155.00 | $8,990.00 |
DisclosureSEC source: 0001467373-18-000072 · wf-form4_151801259853987.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,279 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 21:30 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 1,313 | $160.34 | $210,519.86 |
DisclosureSEC source: 0001467373-18-000065 · wf-form4_151786623546820.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,221 Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:24 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 905 | $156.93 | $142,017.13 |
DisclosureSEC source: 0001467373-18-000041 · wf-form4_151553308550926.xml · nonDerivative · entry 3 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,534 Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:24 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 763 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-18-000041 · wf-form4_151553308550926.xml · nonDerivative · entry 2 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,439 F2 · shares: Grant made pursuant to the Accenture Voluntary Equity Investment Program. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:24 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 752 | $156.93 | $118,007.60 |
DisclosureSEC source: 0001467373-18-000041 · wf-form4_151553308550926.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,676 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Voluntary Equity Investment Program. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 21:25 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 851 | $153.83 | $130,905.08 |
DisclosureSEC source: 0001467373-18-000023 · wf-form4_151501471182247.xml · nonDerivative · entry 2 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,924 Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 21:25 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 4,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-18-000023 · wf-form4_151501471182247.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,775 F1 · kind: Represents a grant of restricted share units awarded under the Accenture plc Amended and Restated 2010 Share Incentive Plan. Read SEC document |
| December 26, 2017 Filed Dec 27, 2017 21:21 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 3,750 | $152.92 | $573,453.00 |
DisclosureSEC source: 0001467373-17-000519 · wf-form4_151440969528067.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,900 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $152.53 to $153.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 13:57 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 61 | $147.63 | $9,005.58 |
DisclosureSEC source: 0001467373-17-000497 · wf-form4_151265505612883.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,650 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:25 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 58 | $144.34 | $8,371.58 |
DisclosureSEC source: 0001467373-17-000484 · wf-form4_151095393538073.xml · nonDerivative · entry 2 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,589 Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:25 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 152 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000484 · wf-form4_151095393538073.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,647 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 05, 2017 Filed Nov 7, 2017 21:22 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 62 | $143.90 | $8,921.49 |
DisclosureSEC source: 0001467373-17-000464 · wf-form4_151008971953600.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,495 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:27 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 6,170 | $139.95 | $863,491.50 |
DisclosureSEC source: 0001467373-17-000453 · wf-form4_150913603431364.xml · nonDerivative · entry 2 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,433 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:27 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 11,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000453 · wf-form4_150913603431364.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,603 Read SEC document |
| October 05, 2017 Filed Oct 10, 2017 12:56 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 67 | $135.82 | $9,099.94 |
DisclosureSEC source: 0001467373-17-000419 · wf-form4_150764020071821.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,633 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 20:28 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,737 | $135.06 | $234,593.31 |
DisclosureSEC source: 0001467373-17-000400 · wf-form4_150706251679642.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,566 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $134.64 to $135.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 20:35 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 69 | $129.75 | $8,952.41 |
DisclosureSEC source: 0001467373-17-000379 · wf-form4_150473011975773.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,303 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| August 05, 2017 Filed Aug 8, 2017 13:09 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 70 | $130.11 | $9,107.35 |
DisclosureSEC source: 0001467373-17-000368 · wf-form4_150219773656939.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,234 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 12:53 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 72 | $124.39 | $8,955.72 |
DisclosureSEC source: 0001467373-17-000322 · wf-form4_149943198888575.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,164 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| June 26, 2017 Filed Jun 28, 2017 00:11 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 400 | $123.66 | $49,464.00 |
DisclosureSEC source: 0001467373-17-000298 · wf-form4_149860868342225.xml · nonDerivative · entry 2 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,092 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $123.47 to $123.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 26, 2017 Filed Jun 28, 2017 00:11 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 2,600 | $122.88 | $319,488.00 |
DisclosureSEC source: 0001467373-17-000298 · wf-form4_149860868342225.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,492 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $122.47 to $123.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 20:38 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 72 | $126.21 | $9,087.13 |
DisclosureSEC source: 0001467373-17-000267 · wf-form4_149678146633759.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,092 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| May 15, 2017 Filed May 16, 2017 20:15 UTC | Accenture plc ACN · Entity 2893 | GrantAccenture plc Class A ordinary shares | 45 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000250 · wf-form4_149496572575140.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,020 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| May 05, 2017 Filed May 8, 2017 20:13 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 74 | $121.14 | $8,964.55 |
DisclosureSEC source: 0001467373-17-000207 · wf-form4_149427438350485.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,975 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 20:06 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 522 | $120.45 | $62,876.36 |
DisclosureSEC source: 0001467373-17-000192 · wf-form4_149340996758532.xml · nonDerivative · entry 2 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,901 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $120.38 to $120.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 20:06 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,700 | $119.82 | $203,688.05 |
DisclosureSEC source: 0001467373-17-000192 · wf-form4_149340996758532.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,423 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $119.38 to $120.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 05, 2017 Filed Apr 6, 2017 20:14 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 76 | $118.29 | $8,990.04 |
DisclosureSEC source: 0001467373-17-000181 · wf-form4_149150965095977.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,123 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| March 05, 2017 Filed Mar 7, 2017 14:09 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 73 | $123.62 | $9,024.08 |
DisclosureSEC source: 0001467373-17-000146 · wf-form4_148889573886012.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,047 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 21:18 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 79 | $114.09 | $9,012.72 |
DisclosureSEC source: 0001467373-17-000075 · wf-form4_148641591464866.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,974 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 13:56 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 1,588 | $113.54 | $180,300.73 |
DisclosureSEC source: 0001467373-17-000060 · wf-form4_148613019953961.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,895 Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 22:51 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 813 | $116.05 | $94,344.59 |
DisclosureSEC source: 0001467373-17-000041 · wf-form4_148374308307378.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,483 Read SEC document |
| January 01, 2017 Filed Jan 4, 2017 21:32 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 865 | $117.27 | $101,438.55 |
DisclosureSEC source: 0001467373-17-000022 · wf-form4_148356555040701.xml · nonDerivative · entry 2 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,296 Read SEC document |
| January 01, 2017 Filed Jan 4, 2017 21:32 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 6,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000022 · wf-form4_148356555040701.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,161 F1 · kind: Represents a grant of restricted share units awarded under the Accenture plc Amended and Restated 2010 Share Incentive Plan. Read SEC document |
| December 23, 2016 Filed Dec 28, 2016 22:38 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 2,648 | $117.64 | $311,508.87 |
DisclosureSEC source: 0001467373-16-001191 · wf-form4_148296466812453.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,766 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $117.37 to $117.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 14:20 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 56 | $116.61 | $6,530.16 |
DisclosureSEC source: 0001467373-16-001149 · wf-form4_147939243476676.xml · nonDerivative · entry 2 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,414 Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 14:20 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 176 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-16-001149 · wf-form4_147939243476676.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,470 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 05, 2016 Filed Nov 8, 2016 21:23 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 154 | $117.28 | $18,061.12 |
DisclosureSEC source: 0001467373-16-001098 · wf-form4_147864018959307.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,294 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| October 24, 2016 Filed Oct 26, 2016 20:24 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 5,297 | $115.99 | $614,399.03 |
DisclosureSEC source: 0001467373-16-001074 · wf-form4_147751347104772.xml · nonDerivative · entry 2 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,140 Read SEC document |
| October 24, 2016 Filed Oct 26, 2016 20:24 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 10,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-16-001074 · wf-form4_147751347104772.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,437 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.